Eli Lilly and Co
XBER:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
XBER:LLY
|
US |
|
C
|
Carlisle Companies Inc
XBER:CLE
|
US |
|
VNV Global AB (publ)
STO:VNV
|
SE |
|
C
|
Cirrus Logic Inc
LSE:0HYI
|
US |
|
C
|
Crayon Group Holding ASA
OSE:CRAYN
|
NO |
|
CH Robinson Worldwide Inc
NASDAQ:CHRW
|
US |
|
Netcare Ltd
OTC:NWKHY
|
ZA |
|
F
|
Fuego Enterprises Inc
OTC:FUGI
|
US |
|
S
|
Sogefi SpA
F:GEF
|
IT |
|
T
|
Tessenderlo Group NV
LSE:0KCP
|
BE |
|
Falcon Gold Corp
OTC:FGLDD
|
CA |
|
P
|
Pampa Energia SA
BCBA:PAMP
|
AR |
|
H
|
Henkel AG & Co KGaA
XMUN:HEN
|
DE |
|
A
|
Advanced Micro Devices Inc
XHAM:AMD
|
US |
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
A
|
Alcoa Corp
ASX:AAI
|
US |
|
Straumann Holding AG
F:QS5
|
CH |
|
G
|
Green Brick Partners Inc
F:2G1
|
US |
|
FirstRand Ltd
F:FSR
|
ZA |
|
Aspen Pharmacare Holdings Ltd
OTC:APNHF
|
ZA |
|
Priority Technology Holdings Inc
NASDAQ:PRTH
|
US |
Bankruptcy Probability
Eli Lilly and Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Eli Lilly and Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
609.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
315.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
142.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Eli Lilly and Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Eli Lilly and Co has total debt of 41.1B USD. This includes both short-term (1.8B USD) and long-term (39.4B USD) debt.
You can find a full breakdown on its Balance Sheet.
